Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-EPCAM, 17-1A Vector   (CAT#: GTVCR-WQ53MR)

This product GTVCR-WQ53MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting EPCAM. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Mus musculus
RefSeq NM_002354.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 4072
UniProt ID P16422
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-EPCAM, 17-1A Vector (GTVCR-WQ53MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ2204MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF4, PF-04518600 Vector Vector PF-04518600
GTVCR-WQ369MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL6, ALD-518 Vector Vector ALD-518
GTVCR-WQ1666MR IVTScrip™ pSP6-VEE-mRNA-Anti-EPHA3, KB-004 Vector Vector KB-004
GTVCR-WQ1384MR IVTScrip™ pT7-VEE-mRNA-Anti-PDCD1, HLX10 Vector Vector HLX10
GTVCR-WQ1818MR IVTScrip™ pSP6-VEE-mRNA-Anti-FOLR1, M9346A Vector Vector M9346A
GTVCR-WQ169MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD40, ABBV-323 Vector Vector ABBV-323
GTVCR-WQ1130MR IVTScrip™ pSP6-VEE-mRNA-Anti-EGFR, DS 1024 Vector Vector DS 1024
GTVCR-WQ1472MR IVTScrip™ pT7-VEE-mRNA-Anti-PCSK9, IBI-306 Vector Vector IBI-306
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW